Additionally, Xu et al. found that RBCK1 appreciably facilitated the invasive and metastatic capacity of HCC by enhancing glucose transporter 1 (GLUT1)-dependent aerobic glycolysis and disrupting the PPARγ or PPARγ/PGC1α complex [14]. The gene discussed is PPARGC1A; the disease is hepatocellular carcinoma.